Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.
about
Lurasidone for the treatment of bipolar depression: an evidence-based reviewThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmNoradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episodeAntipsychotic-like effects of a neurotensin receptor type 1 agonist.Effectiveness of the Dader Method for pharmaceutical care in patients with bipolar I disorder: EMDADER-TAB: study protocol for a randomized controlled trialAcute interventions and referral of patients with bipolar disorder by the psychiatric consultation liaison service in a general hospital in Germany: a retrospective analysis.Antidepressants for bipolar disorder: A meta-analysis of randomized, double-blind, controlled trials.Mania: diagnosis and treatment recommendations.Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study.Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) ReportEvaluation of left ventricular systolic and diastolic functions in bipolar patients during lithium therapyRoyal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.How assess drugs in the treatment of acute bipolar mania?Adjunctive Methylphenidate in the Treatment of Bulimia Nervosa Co-occurring with Bipolar Disorder and Substance Dependence.The Use of Antidepressants in the Long-Term Treatment Should not Improve the Impact of Fibromyalgia on Quality of Life.Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care serviceMisdiagnosed hypomanic symptoms in patients with treatment-resistant major depressive disorder in Italy: results from the improve study.Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review.Pharmacogenomics of bipolar disorder.The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia.Clozapine use reduced psychiatric hospitalization and emergency room visits in patients with bipolar disorder independent of improved treatment regularity in a three-year follow-up period.Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy.Revisiting loxapine: a systematic review.Psychosocial treatment and interventions for bipolar disorder: a systematic review.Experimental drugs for bipolar psychosis.The impact of depressive and bipolar symptoms on socioeconomic status, core symptoms, function and severity of fibromyalgia.Risk factors for rapid cycling in bipolar disorder.Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid.Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples.Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression.The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study.Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study.Ebselen has lithium-like effects on central 5-HT2A receptor function.Aggression in Psychoses
P2860
Q26796437-25A4772A-3062-41D3-B35A-3569105B1936Q28066714-BEDE2962-7DB9-4827-8B68-FBED2217DFD8Q28076943-31263FC3-A2A4-4C08-AC78-2E4881CEDE61Q30356261-5EF9CF23-987B-49AE-BD49-E34D4B31E68FQ33712815-D3D661F1-EA10-44AC-ADCA-A354B335CD3CQ33975833-C2D9F76A-8BD1-4803-9A11-32502A9A57B0Q34095729-FFF879CC-54D4-4710-A6D5-7AB87D49814BQ34300315-5988B92A-6751-4144-8045-6D0C4D4DBE21Q34644698-0FAC41F5-6055-4D7A-87AC-99B166E71C89Q34804607-D70FACF4-CC59-4BBF-813C-57EB4290018BQ35481734-15836151-F8A5-4BF9-BE3C-F2A542616866Q35862776-460B0CEF-BCF0-4C7F-BBF7-6A594BBFB6D2Q36010076-7F877306-D53F-4023-85FC-AF77948B49A2Q36568973-7885A1BF-9D0F-49EA-9C5C-AA603CB53D4AQ36737410-BB96C20A-ACDC-41ED-AB39-214FF36FC90FQ37076446-78136FEB-4629-4C73-BA0D-D8812BA437E1Q37115466-1E1A5770-5A72-450F-BAE2-571D39349A2DQ37718568-6D8247A8-0756-4F57-A06A-7952D5C0B487Q38092894-110135C2-8DBD-40F0-850B-C2074DF3CFA6Q38097534-1D9C3139-DDD3-461A-A01B-DEE186F24879Q38120295-1C440A43-60E7-4BC4-A6ED-C2CE0ACEF72AQ38258128-36B37A9E-8E30-406F-B9A0-86D220D22E7BQ38303164-BC863F59-ADEF-4052-A3EB-29FB3B4B2CDAQ38413932-C7D4929F-9EB1-4809-95A7-4E2429EE2AB6Q38544047-564E22FF-5642-46AD-9178-80A4704C7F51Q38995982-858236E6-D84B-4416-97E3-ED7F625E8A26Q40673131-14B36F09-80D7-499E-8009-30307E0D8B5BQ41434848-69F6CEEC-87AB-4261-83D9-A849B238764DQ44403456-10C6F27C-AD5D-4572-8361-5082AC159B09Q45894972-BDE8E7B2-9224-42FF-8B3E-9AD2C441ECB0Q46122791-5F8557C4-64F7-44DE-9202-B09F29833538Q47285494-5DF1A137-185B-4F92-B6D1-973CAD5A8241Q47553823-99163A73-13AB-4C4D-A37E-D8035BAFB06FQ48248419-10E0D406-817A-4109-BFF2-7993B5C2AD8EQ48448795-AB73C879-36D9-4730-B3DA-32FA15D0D4DFQ53445382-59F9BF02-7CE3-4F51-9512-DA6CCDD06C5CQ59048862-0767BDB7-E157-48EE-B643-C2FD9F80BEA5
P2860
Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Efficacy of pharmacotherapy in ...... section on pharmacopsychiatry.
@en
type
label
Efficacy of pharmacotherapy in ...... section on pharmacopsychiatry.
@en
prefLabel
Efficacy of pharmacotherapy in ...... section on pharmacopsychiatry.
@en
P2093
P50
P1476
Efficacy of pharmacotherapy in ...... section on pharmacopsychiatry.
@en
P2093
Ahmed Okasha
Emanuel Severus
Konstantinos N Fountoulakis
Marcio Versiani
Pierre Blier
Rajiv Tandon
P2888
P356
10.1007/S00406-012-0323-X
P478
262 Suppl 1
P577
2012-06-01T00:00:00Z
P5875
P6179
1005620841